Why Ocugen Shares Skyrocketed Today

Benzinga2021-04-23

Ocugen Inc OCGN 42.92% shares soared 42.9% in the regular session and another 11% in the after-hours session on Thursday.

What Happened: The shares surged following positive clinical data announced by a partner of Ocugen and a bullish stance taken by Roth Capital analyst Zegbeh Jallah who has a Buy rating on the stock and a 12-month price target of $10.

Earlier, on Wednesday, Ocugen’s co-development partner Bharat Biotech said that the second interim analysis of Phase 3 of Covaxin, a COVID-19 vaccine candidate, shows itdemonstrated 78% efficiencyin mild, moderate, and severe disease.

The vaccine is reportedly 100% effective against severe forms of viral illness.

In a note, Jallah said that Ocugen has sufficient information to support the filing of an Emergency Use Authorization application in the United States.

“If granted, this could lead to a significant revenue generating opportunity for Ocugen,” wrote the analyst.

Jallah said that management has confirmed plans to make Covaxin available in the U.S.

The vaccine’s initial batches will undergo test and release at a U.S. facility approved by the Food and Drug Administration, as per Jallah.

Meanwhile, Bharat Biotech isramping up manufacturingto produce 700 million COVID-19 vaccine doses annually.

Earlier in the month, it was reported that Ocugen plans to sell100 million Covaxin dosesin the U.S.

Price Action: Ocugen shares closed 42.92% higher at $9.29 on Thursday and rose another almost 11% to $10.31 in the after-hours trading.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

  • koonkoon
    2021-04-24
    koonkoon
    Wow
    • Oth
      👍🏻👍🏻
  • Shermianz
    2021-04-24
    Shermianz
    @EvanHuatsee this.
  • Kaboom
    2021-04-23
    Kaboom
    But there is a world wide shortage on manufacturing materials like vials, filter bags etc. That’s why Novavax can’t ramp up 
  • KeeBoonTong
    2021-04-23
    KeeBoonTong
    Wow
  • KeeBoonTong
    2021-04-23
    KeeBoonTong
    Hihi
  • Cfgramos
    2021-04-23
    Cfgramos
    Health wise, this is good news. Lucky for those who already bought it at the dip.
发表看法
10